Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 9c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q4 EPS of ($0.19), $0.09 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $28.93 million versus the consensus estimate of $31.8 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Wall Street's new pair trade: Long software, short chips
• Morgan Stanley Downgrades Stellantis NV (STLA:FP) (STLA) to Underweight
• H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)